Neurology in Arizona

Cranial Technologies, Inc. is a specialized pediatric medical device company focused exclusively on the diagnosis and treatment of plagiocephaly (flat head syndrome) and infant ear shape deformities. Founded over 35 years ago, the company designs and manufactures the DOC Band®, a custom-molded cranial orthotic device engineered to gently reshape infants' heads during critical developmental periods. The company operates a network of clinical evaluation centers across the United States where certified clinicians conduct free head shape assessments using Digital Surface Imaging® technology to capture precise measurements of each infant's unique anatomy. Custom DOC Bands are then fabricated based on these digital images and fitted in subsequent appointments. The company also offers Earwell®, a device for early ear shape correction, and Inchbug™, a line of clinician-approved decorative stickers for helmet customization. Cranial Technologies serves pediatric patients, families, and healthcare providers (pediatricians, pediatric neurologists, physical therapists, and craniofacial specialists). The company emphasizes evidence-based treatment protocols, clinical research contributions to plagiocephaly management, and family-centered care with parent support communities. Insurance coverage is available for DOC Band treatment at many major carriers. The company maintains multiple clinic locations and operates an online booking system for evaluations. No specific FDA regulatory classifications or ISO certifications are mentioned on the website, though the products are medical devices intended for therapeutic use.

Noraxon USA is a leader in human movement metrics and biomechanics research solutions, operating for over 30 years from Scottsdale, Arizona. The company specializes in integrated measurement technologies for analyzing human movement across research, clinical, sports, and ergonomic applications. Noraxon provides FDA-approved, patent-protected hardware and software including EMG sensors for muscle activity assessment, force and pressure sensors for ground reaction force measurement, 3D motion capture systems with integrated video technology, and proprietary data acquisition and analysis software (MR4/MR3XP) tailored for life sciences. Their modular, customizable platforms enable researchers, clinicians, and sports scientists to build complete biomechanics laboratories. The company serves university research departments, clinical rehabilitation facilities, sports performance centers, and occupational ergonomics programs with a global distribution network and multiple international certifications.

Anuncia Medical is a neurotherapeutic medical device company based in Scottsdale, Arizona, specializing in cerebrospinal fluid (CSF) management and neurocritical care solutions. The company develops noninvasive, clinically validated breakthrough devices designed to monitor, treat, and prevent shunt occlusions in patients with hydrocephalus. The ReFlow™ System Mini (ReFlow™ Mini Flusher) is their primary offering—an implantable device that allows patients to perform noninvasive CSF flushes by pressing the flusher located under the scalp, potentially restoring or maintaining shunt patency and reducing the need for repeat revision brain surgeries. The device received FDA Breakthrough Device Designation, indicating significant clinical potential. Anuncia addresses the substantial unmet need in hydrocephalus management, particularly affecting pediatric and geriatric populations. The company's team comprises medical device veterans collaborating with leading institutions and clinicians. Their technology targets both in-clinic and at-home management scenarios, reducing patient morbidity and healthcare costs associated with shunt revision procedures. The ReFlow™ Mini Flusher can be used with the ReFlow™ Ventricular Catheter, which features a relief membrane backup option providing alternate CSF flow pathways. Regulatory credentials include FDA Breakthrough Device Designation. The company actively engages with patient communities and professional associations to support hydrocephalus awareness and clinical education.

LifeStance Health

LifeStance Health is a prominent outpatient behavioral health provider in the U.S., founded in 2017 and headquartered in Scottsdale, Arizona. The company operates over 550 centers across 33 states and offers nationwide telehealth services. LifeStance is publicly traded on NASDAQ under the ticker LFST, having completed its IPO in 2021. The company provides a range of mental health services, including therapy and counseling for individuals, couples, and families, as well as psychiatry and medication management. LifeStance also offers psychological testing and specialized treatments like Transcranial Magnetic Stimulation (TMS) and ketamine therapies. With a focus on evidence-based care, LifeStance emphasizes personalized treatment plans and continuity of care, accepting over 160 commercial insurance plans and some Medicaid options. The company employs around 7,500 licensed mental health professionals and has adapted its services to include a significant telehealth component, making mental health care more accessible to patients.